Tatva Chintan Pharma Chem Ltd Share Price (TATVA)
₹1252.85▲1.16%
Tatva Chintan Pharma Chem Ltd share Performance
- ₹1232.05₹1270.1₹1252.85
1.66%
Low
Day's Volatility:3.04%
High
1.38%
- ₹1061.35₹1887.95₹1252.85
15.29%
Low
52 Weeks Volatility:65.98%
High
50.69%
| Returns % | |
| 1 Month Return | 9.75 % |
| 3 Month Return | -8.94 % |
| 1 Year Return | -24.32 % |
| Market Stats | |
| Previous Close | ₹1,238.45 |
| Open | ₹1,245.00 |
| Volume | 10.46K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,896.99Cr |
Analyst Rating for Tatva Chintan Pharma Chem Ltd stock
based on 4 analysts
Based on 4 analysts offering long term price targets for Tatva Chintan Pharma Chem Ltd. An average target of ₹1674.25
Source: S&P Global Market Intelligence
Company Information
Share Price: ₹1252.85 per share as on 24 Apr, 2024 04:01 PM
Market Capitalisation: ₹2,896.99Cr as of today
Revenue: ₹84.21Cr as on December 2023 (Q4 23)
Net Profit: ₹3.46Cr as on December 2023 (Q4 23)
Listing date: 29 Jul, 2021
Chairperson Name: Chintan Nitinkumar Shah
| Organisation | Tatva Chintan Pharma Chem Ltd |
| Headquarters | Vadodara |
| Industry | Chemicals |
| E-voting on shares | Click here to vote |
Key events for Tatva Chintan Pharma Chem Ltd
Analysts Predict Positive Earnings Outlook for Tatva Chintan Pharma Chem - 04 Apr, 2024
Tatva Chintan Pharma Chem's high P/E ratio is due to a positive earnings outlook, with analysts forecasting a significant increase in EPS. Prabhudas Lilladher has issued a buy call with a target price of Rs 1590.
Analysts Recommend Going Long on Tatva Chintan Pharma Chem Ltd - 03 Apr, 2024
Parekh and PL have recommended accumulating shares of Tatva Chintan Pharma Chem Ltd with an upside target of Rs 1,450-1,800. The stock is showing signs of bottoming out and has a support level of Rs 1,400. A strict stop loss of Rs 1,060 should be maintained.
Delay in EU 7 Implementation Poses Risk to SDA Growth for Tatva Chintan Pharma Chem Ltd - 21 Mar, 2024
The delay in the implementation of EU 7 norms related to limiting vehicle emissions may pose a risk to the growth of structural directing agents (SDA) for Tatva Chintan Pharma Chem Ltd. The delay is expected to push incremental demand from the USA and Europe further down the line, leading to moderate SDA growth post FY25 till FY27. This might lead to consensus earnings downgrades over the next two years.
Fundamentals of Tatva Chintan Pharma Chem Ltd
Insights on Tatva Chintan Pharma Chem Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 10.71% to 11.49% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Aarti Industries Ltd has given 34.6% return, outperforming this stock by 58.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.02% of holdings in Mar 2024 quarter
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 4 quarters, 125.36 Cr → 85.42 Cr (in ₹), with an average decrease of 12.0% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 13.05% to 12.84% in Mar 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 16.95 Cr → 3.46 Cr (in ₹), with an average decrease of 39.2% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 4.21% to 3.65% in Mar 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 6 months, TATVA stock has moved down by -15.0%
Tatva Chintan Pharma Chem Ltd Valuation
Tatva Chintan Pharma Chem Ltd in the last 5 years
Lowest (44.37x)
October 20, 2021
Industry (38.53x)
April 23, 2024
Today (73.50x)
April 23, 2024
Highest (104.85x)
January 20, 2023
Mutual Fund Holdings
| Funds | Holdings |
 Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option | 0.58% |
 SBI Magnum Midcap Fund Direct Growth | 0.41% |
| Nippon India Small Cap Fund - Direct Plan - Growth Plan | 0.14% |
 ICICI Prudential Smallcap Fund Direct Plan Growth | 0.45% |
 Mirae Asset Aggressive Hybrid Fund -Direct Plan-Growth | 0.3% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.02% | 0.00 | |
| Foreign Institutions | 3.65% | 0.00 | |
| Mutual Funds | 12.84% | 0.00 | |
| Retail Investors | 11.49% | 0.00 | |
| Others | 0% | 0.00 |
Technicals of Tatva Chintan Pharma Chem Ltd share
News & Events of Tatva Chintan Pharma Chem Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Tatva Chintan Pharma Chem Ltd shares.
Tatva Chintan Pharma Chem Ltd (TATVA) share price today is ₹1252.85
Tatva Chintan Pharma Chem Ltd is listed on NSE
Tatva Chintan Pharma Chem Ltd is listed on BSE
- Today’s highest price of Tatva Chintan Pharma Chem Ltd is ₹1270.1.
- Today’s lowest price of Tatva Chintan Pharma Chem Ltd is ₹1232.05.
PE Ratio of Tatva Chintan Pharma Chem Ltd is 73.5
PE ratio = Tatva Chintan Pharma Chem Ltd Market price per share / Tatva Chintan Pharma Chem Ltd Earnings per share
Today’s traded volume of Tatva Chintan Pharma Chem Ltd(TATVA) is 10.46K.
Today’s market capitalisation of Tatva Chintan Pharma Chem Ltd(TATVA) is ₹2896.99Cr.
| Tatva Chintan Pharma Chem Ltd(TATVA | Price |
|---|---|
52 Week High | ₹1887.95 |
52 Week Low | ₹1061.35 |
Tatva Chintan Pharma Chem Ltd(TATVA) share price is ₹1252.85. It is down -33.64% from its 52 Week High price of ₹1887.95
Tatva Chintan Pharma Chem Ltd(TATVA) share price is ₹1252.85. It is up 18.04% from its 52 Week Low price of ₹1061.35
| Tatva Chintan Pharma Chem Ltd(TATVA | Returns |
|---|---|
1 Day Returns | 14.4% |
1 Month Returns | 9.75% |
3 Month Returns | -8.94% |
1 Year Returns | -24.32% |